Market Trends of Global Mammography Industry
This section covers the major market trends shaping the Mammography Market according to our research experts:
The Digital Mammography Segment is Expected to Account for the Large Market Share During the Forecast Period
As breast cancer patients are at higher risk of acquiring the infection, many organizations took definite measures to manage these diseases. According to a research article by Dafina Petrova et al., published in Medicina Clínica Journal in September 2020, the European Society for Medical Oncology (ESMO), the Spanish Society of Radiation Oncology (SEOR), and the Spanish Society of Medical Oncology (SEOM) have published some recommendations on how to modify treatment protocols to minimize risks in cancer patients. The improved guidelines would provide more efficient methods to perform surgeries which would have a positive impact on the treatments. Such instances are expected to support the growth of the digital mammography market. With the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts.
Product launches are another factor for segmental growth. For instance, in August 2021, FUJIFILM Medical Systems U.S.A., Inc. launched ScreenPoint Medical's, FDA cleared Transpara powered by Fusion AI for 2D and 3D mammography in the United States. Additionally, In April 2021, Fujifilm Europe GmbH launched the 'Harmony' version of its Amulet Innovality mammography system in Germany. AMULET Innovality is a Full Field Digital Mammography (FFDM) equipped with Fujifilm's unique and innovative technologies that achieve optimum image quality at a very low patient dose. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems.
Radiation exposure is significantly lower as compared to analog systems. All these advantages aid in the growth of the market over the forecast period. Moreover, as per the American Cancer Society, in 2021, about 287,850 cases of invasive breast cancer were diagnosed in women. Thus, the rising prevalence of breast cancer is likely to boost the demand for digital mammography.
Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.
North America Accounts for the Large Share in the Global Market Over the Forecast Period
North America is found to hold a major share of the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period.
Due to the outbreak of COVID-19, the market is expected to face a slight setback owing to the delay in diagnosis, drug shortages, and others. However, as lockdowns and restrictions are getting relaxed, there may be an increase in demand for mammography services. Many women who had canceled their appointments or had their visits for mammography services postponed are now able to get their tests done. The Breast Cancer Research Foundation in the United States has stated that hospitals and facilities in most places are well prepared and safe now as compared to the initial days of the COVID-19 pandemic. Thus, it has been encouraging women to get their scheduled scans done so that diagnosis is not delayed.
According to the American Cancer Society, in 2020, an estimated 276,480 new cases of invasive breast cancer have been diagnosed among women. Additionally, 48,530 cases of in situ breast carcinoma have been diagnosed among women, and the number of breast cancer cases is expected to increase in the coming years.
Furthermore, several companies are found launching programs to support breast cancer tests. For example, in August 2020, Hologic Inc. reported the Back to Screen campaign launch, which may encourage women to schedule their delayed mammograms due to the COVID-19 pandemic.
The growth is also being fueled by the launch and growing adoption of advanced mammography devices with innovative technologies. For instance, in October 2021, FUJIFILM Canada Inc. received a Health Canada medical device license for its ASPIRE Cristalle digital mammography solution. It also expanded its partnership with Christie Innomed to offer the product across every province in Canada.
Thus, owing to the rising prevalence of breast cancer and product launches, the market is expected to experience growth over the forecast period.
